vs
agilon health, inc.（AGL）与RENAISSANCERE HOLDINGS LTD（RNR）财务数据对比。点击上方公司名可切换其他公司
RENAISSANCERE HOLDINGS LTD的季度营收约是agilon health, inc.的1.4倍（$2.2B vs $1.6B），RENAISSANCERE HOLDINGS LTD净利率更高（23.5% vs -12.0%，领先35.5%），agilon health, inc.同比增速更快（3.1% vs -36.8%），过去两年agilon health, inc.的营收复合增速更高（-1.1% vs -11.9%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
RenaissanceRe Holdings Ltd是总部位于百慕大的保险及相关商业服务提供商，核心业务覆盖再保险、常规保险两大板块，同时运营风险相关创新投资业务，为全球客户提供专业的风险对冲与保险解决方案。
AGL vs RNR — 直观对比
营收规模更大
RNR
是对方的1.4倍
$1.6B
营收增速更快
AGL
高出39.8%
-36.8%
净利率更高
RNR
高出35.5%
-12.0%
两年增速更快
AGL
近两年复合增速
-11.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $2.2B |
| 净利润 | $-188.9M | $515.8M |
| 毛利率 | — | — |
| 营业利润率 | -12.3% | — |
| 净利率 | -12.0% | 23.5% |
| 营收同比 | 3.1% | -36.8% |
| 净利润同比 | -78.5% | 72.6% |
| 每股收益（稀释后） | — | $6.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGLRNR
| Q1 26 | — | $2.2B | ||
| Q4 25 | $1.6B | $3.0B | ||
| Q3 25 | $1.4B | $3.2B | ||
| Q2 25 | $1.4B | $3.2B | ||
| Q1 25 | $1.5B | $3.5B | ||
| Q4 24 | $1.5B | $2.3B | ||
| Q3 24 | $1.5B | $4.0B | ||
| Q2 24 | $1.5B | $2.8B |
净利润AGLRNR
| Q1 26 | — | $515.8M | ||
| Q4 25 | $-188.9M | $760.5M | ||
| Q3 25 | $-110.2M | $916.5M | ||
| Q2 25 | $-104.4M | $835.4M | ||
| Q1 25 | $12.1M | $170.0M | ||
| Q4 24 | $-105.8M | $-189.7M | ||
| Q3 24 | $-117.6M | $1.2B | ||
| Q2 24 | $-30.7M | $503.9M |
营业利润率AGLRNR
| Q1 26 | — | — | ||
| Q4 25 | -12.3% | 42.5% | ||
| Q3 25 | -9.1% | 46.3% | ||
| Q2 25 | -8.3% | 41.8% | ||
| Q1 25 | -1.4% | -2.0% | ||
| Q4 24 | -7.1% | -3.6% | ||
| Q3 24 | -9.2% | 43.7% | ||
| Q2 24 | -2.9% | 25.0% |
净利率AGLRNR
| Q1 26 | — | 23.5% | ||
| Q4 25 | -12.0% | 25.6% | ||
| Q3 25 | -7.7% | 28.7% | ||
| Q2 25 | -7.5% | 26.1% | ||
| Q1 25 | 0.8% | 4.9% | ||
| Q4 24 | -6.9% | -8.3% | ||
| Q3 24 | -8.1% | 29.8% | ||
| Q2 24 | -2.1% | 17.8% |
每股收益（稀释后）AGLRNR
| Q1 26 | — | $6.57 | ||
| Q4 25 | — | $16.16 | ||
| Q3 25 | — | $19.40 | ||
| Q2 25 | — | $17.20 | ||
| Q1 25 | — | $3.27 | ||
| Q4 24 | — | $-3.76 | ||
| Q3 24 | — | $22.62 | ||
| Q2 24 | — | $9.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | $1.6B |
| 总债务越低越好 | $35.0M | — |
| 股东权益账面价值 | $126.7M | $4.3B |
| 总资产 | $1.3B | $53.7B |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资AGLRNR
| Q1 26 | — | $1.6B | ||
| Q4 25 | $173.7M | $1.7B | ||
| Q3 25 | $171.7M | $1.7B | ||
| Q2 25 | $171.4M | $1.4B | ||
| Q1 25 | $136.9M | $1.6B | ||
| Q4 24 | $188.2M | $1.7B | ||
| Q3 24 | $148.2M | $1.6B | ||
| Q2 24 | $109.5M | $1.6B |
总债务AGLRNR
| Q1 26 | — | — | ||
| Q4 25 | $35.0M | $2.3B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $2.0B |
股东权益AGLRNR
| Q1 26 | — | $4.3B | ||
| Q4 25 | $126.7M | $11.6B | ||
| Q3 25 | $306.1M | $11.5B | ||
| Q2 25 | $408.9M | $10.8B | ||
| Q1 25 | $500.3M | $10.3B | ||
| Q4 24 | $471.0M | $10.6B | ||
| Q3 24 | $574.9M | $11.2B | ||
| Q2 24 | $676.6M | $10.2B |
总资产AGLRNR
| Q1 26 | — | $53.7B | ||
| Q4 25 | $1.3B | $53.8B | ||
| Q3 25 | $1.6B | $54.5B | ||
| Q2 25 | $1.7B | $54.7B | ||
| Q1 25 | $1.9B | $53.6B | ||
| Q4 24 | $1.7B | $50.7B | ||
| Q3 24 | $2.1B | $52.8B | ||
| Q2 24 | $2.2B | $51.6B |
负债/权益比AGLRNR
| Q1 26 | — | — | ||
| Q4 25 | 0.28× | 0.20× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.21× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.17× | ||
| Q2 24 | — | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | — |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | — |
| 自由现金流率自由现金流/营收 | -1.5% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-119.0M | — |
8季度趋势，按日历期对齐
经营现金流AGLRNR
| Q1 26 | — | — | ||
| Q4 25 | $-20.5M | $483.0M | ||
| Q3 25 | $-18.2M | $1.6B | ||
| Q2 25 | $-35.1M | $1.5B | ||
| Q1 25 | $-32.0M | $157.8M | ||
| Q4 24 | $16.4M | $778.9M | ||
| Q3 24 | $-7.7M | $1.5B | ||
| Q2 24 | $-18.7M | $1.2B |
自由现金流AGLRNR
| Q1 26 | — | — | ||
| Q4 25 | $-23.5M | — | ||
| Q3 25 | $-21.3M | — | ||
| Q2 25 | $-38.3M | — | ||
| Q1 25 | $-35.8M | — | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $-11.2M | — | ||
| Q2 24 | $-22.0M | — |
自由现金流率AGLRNR
| Q1 26 | — | — | ||
| Q4 25 | -1.5% | — | ||
| Q3 25 | -1.5% | — | ||
| Q2 25 | -2.7% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | -0.8% | — | ||
| Q2 24 | -1.5% | — |
资本支出强度AGLRNR
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.2% | — |
现金转化率AGLRNR
| Q1 26 | — | — | ||
| Q4 25 | — | 0.64× | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | — | 1.76× | ||
| Q1 25 | -2.64× | 0.93× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.26× | ||
| Q2 24 | — | 2.41× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
RNR
暂无分部数据
